Cardiovasc Pathol. 2014 Jan-Feb;23(1):17-20. doi: 10.1016/j.carpath.2013.06.005. Epub 2013 Aug 6.
PMID:23928368
Concurrent Fulminant Myocarditis and Severe Rhabdomyolysis in COVID-19-related Multisystem Inflammatory Syndrome in Adults: A Case Report and Review of the Literature.
Ono R, Iwahana T, Aoki K, Kato H, Hattori N, Oshima T, Kouchi Y, Hashimoto R, Kishimoto T, Ikeda JI, Kobayashi Y.
Acute Myocarditis with Severe Fever and Thrombocytopenia Syndrome.
Okutsu S, Futami M, Arimura T, Ohki K, Hiyoshi T, Sakihara E, Kato Y, Ueda Y, Yano M, Takeshita M, Ishikura H, Suzuki T, Kato S, Miura SI, Nabeshima S.
Intern Med. 2022;61(11):1779-1784. doi: 10.2169/internalmedicine.7018-21. Epub 2022 Jun 1.
PMID:35650116
Early evaluation of severe immune checkpoint inhibitor-associated myocarditis: a real-world clinical practice.
Tang X, Li Y, Huang H, Shi R, Shen LT, Qian WL, Yang ZG.
J Cancer Res Clin Oncol. 2023 Sep;149(11):8345-8357. doi: 10.1007/s00432-023-04782-3. Epub 2023 Apr 19.
PMID:37076643
Immunopathogenesis and immunomodulatory therapy for myocarditis.
He W, Zhou L, Xu K, Li H, Wang JJ, Chen C, Wang D.
Sci China Life Sci. 2023 Sep;66(9):2112-2137. doi: 10.1007/s11427-022-2273-3. Epub 2023 Mar 29.
PMID:37002488
CXCR6(+) T Cells Drive Immune Checkpoint Inhibitor Myocarditis.
Munir AZ, Gutierrez A, Krawiec CJ, Manandhar P, Shyani AC, Ma P, Gougis P, Baylis RA, Hou L, Remold-O'Donnell E, Balko JM, Salem JE, Lavine KJ, Lichtman AH, Qin J, Moslehi JJ.
Circulation. 2026 Mar 10;153(10):754-768. doi: 10.1161/CIRCULATIONAHA.125.076976. Epub 2026 Jan 7.